Colin Goddard is CEO at OSI PHARMACEUTICALS INC (OSIP). They have made 2 open-market trades across 1 company since 2006, most recently 2018-12-21.
CIK 0001225199
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $123K since 2011, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HGSI | BUY | 2011-08-04 | 2011-08-05 | $16.17 | $49K | N/A | N/A | N/A |
| HGSI | BUY | 2011-03-22 | 2011-03-23 | $27.41 | $75K | N/A | N/A | N/A |
| OSIP | SELL · 10b5-1 | 2010-03-01 | 2010-03-03 | $55.17 | $3.6M | N/A | N/A | N/A |
| OSIP | SELL · 10b5-1 | 2007-06-04 | 2007-06-06 | $36.98 | $1.5M | N/A | N/A | N/A |
| OSIP | SELL · 10b5-1 | 2006-08-25 | 2006-08-29 | $36.05 | $982K | N/A | N/A | N/A |
| OSIP | SELL · 10b5-1 | 2006-08-25 | 2006-08-29 | $36.32 | $100K | N/A | N/A | N/A |
| OSIP | SELL · 10b5-1 | 2006-06-02 | 2006-06-06 | $30.13 | $723K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.